Longitude Capital Partners II LLC 13D and 13G filings for Kala Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-18 4:04 pm Unchanged |
2023-05-01 | 13D | Kala Pharmaceuticals, Inc. KALA |
Longitude Capital Partners II LLC | 108,239 4.300% |
0 (Unchanged) |
Filing |
| 2023-02-14 4:15 pm Sale |
2022-12-31 | 13D | Kala Pharmaceuticals, Inc. KALA |
Longitude Capital Partners II LLC | 108,239 6.300% |
-110,042 (-50.41%) |
Filing |